Buserelin contains a modified peptide backbone that stabilizes secondary-structure elements and enhances interaction studies. Its residue composition supports conformational flexibility and solvent-dependent transitions. Researchers evaluate its binding determinants and hydrogen-bond networks. Applications include peptide engineering, biophysical analysis, and structural modeling.
CAT No: R2693
CAS No:57982-77-1
Synonyms/Alias:BUSERELIN;57982-77-1;Etilamide;Buserelina;Busereline;Buserelinum;Metrelef;Tiloryth;PXW8U3YXDV;UNII-PXW8U3YXDV;(Des-Gly10,D-Ser(tBu)6,Pro-NHEt9)-LHRH;ICI 123215;CCRIS 2657;HOE 766A;Busereline [INN-French];Buserelinum [INN-Latin];EINECS 261-061-9;Buserelina [INN-Spanish];HOE 766;(D-Ser(tbu)(sup 6)-EA(sup 10))-LHRH;Buserelin (INN);S 746766;BUSERELIN [INN];(D-Ser(Bu(sup t)(sup 6)))-LH-RH(1-9)nonapeptide-ethylamide;Busereline (INN-French);Buserelinum (INN-Latin);Buserelina (INN-Spanish);BUSERELIN (MART.);BUSERELIN [MART.];BUSERELIN (EP MONOGRAPH);BUSERELIN [EP MONOGRAPH];NSC725176;Buserelin [INN:BAN];Tiloryth (TN);BSRL;Buserelin acetate salt;D-Ser-(TBu)(sup 6)-LHRH-ethylamide;BUSERELIN [MI];BUSERELIN [WHO-DD];SCHEMBL13354;GTPL3860;Buserelin for NMR identification;CHEMBL2110824;D-Ser(tbu(sup 6))-LH-RH-(1-9)-nonapeptide ethylamide;SCHEMBL19409318;SCHEMBL19459955;Buserelin for peak identification;L02AE01;CHEBI:135907;CUWODFFVMXJOKD-UVLQAERKSA-N;DTXSID301024155;MFCD00941414;AKOS015994645;AKOS030213242;HS-2005;NCGC00181295-01;FD109219;D07259;Q414745;S74-6766;(Des-Gly10,D-Ser(tBu)6,Pro-NHEt 9)-LHRH acetate salt;des-Gly10-[D-Ser[t-Bu]6]-LH-RH ethylamide acetate salt;pGlu-His-Trp-Ser-Tyr-D-Ser(t-Bu)-Leu-Arg-Pro-NHEt acetate salt;Pyr-His-Trp-Ser-Tyr-D-Ser(tBu)-Leu-Arg-Pro-NHEt; pE-HWSY(dS)(tBu)LRP-NHEt;261-061-9;5-oxo-l-prolyl-l-histidyl-l-tryptophyl-l-seryl-l-tyrosyl-o-tert-butyl-d-seryl-l-leucyl-l-arginyl-n-ethyl-l-prolinamide;6-(O-(1,1-Dimethylethyl)-D-serine)-9-(N-ethyl-L-prolinamide)-10-deglycinamide Luteinizing Hormone-Releasing Factor (Pig);6-(O-(1,1-Dimethylethyl)-D-serine)-9-(N-ethyl-L-prolinamide)-10-deglycinamide-luteinizing Hormone-releasing Factor (Pig);
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.